ADMT — what changed in the latest 10-Q
A section-by-section comparison of ADMT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-19 vs the prior 10-Q · 2026-02-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +12 | −19 | ~4 | 4 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~3 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 3 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-19
The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM. Sonotron Medical Systems, Inc. (“SMI”), a former wholly owned subsidiary of ADM, had been inactive for several years and was dissolved during the fi…
Revenues for the three months ended June 30, 2026 decreased by $107,420, or 11.0%, compared to the same period in 2025. Chemical segment revenue decreased by $9,200 to $325,860, Electronics segment revenue decreased by $41,692 to $472,990, and Engineering segment revenue decreased by $56,528 to $67,…
Gross profit for the three months ended June 30, 2026 decreased by $86,243, or 17.4%, compared to the same period in 2025, and gross profit margin declined to 46% from 49%. Gross margin declined across all three segments, with the largest declines in the Chemical segment, to 30% from 39%, and the En…
Operating expenses for the three months ended June 30, 2026 increased by $43,646, or 12.1%, compared to the same period in 2025, driven by increases of $30,447 in the Chemical segment and $30,616 in the Electronics segment, partially offset by a $15,904 decrease in the Engineering segment.
Operating income (loss) for the three months ended June 30, 2026 decreased by $129,889 compared to the prior year, resulting in an operating loss of $19,772 for the current period as compared to operating income of $109,234 in the prior year period.
Text removed vs the prior filing · source: 10-Q · 2026-02-13
The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM and its subsidiary Sonotron.
Revenues for the three months ended December 31, 2025, increased by $53,578 compared to the same period in 2024. The increase was driven by a $14,980 rise in the Chemical segment and a $96,460 increase in the Electronics segment, partially offset by a $57,862 decline in the Engineering segment.
Revenues for the nine months ended December 31, 2025, increased by $216,870 compared to the same period in 2024. The increase was driven by a $44,554 rise in the Chemical segment and a $333,630 increase in the Electronics segment, partially offset by a $163,314 decline in the Engineering segment.
Gross profit for the three months ended December 31, 2025 increased by $4,317. This increase was primarily due to a $4,017 increase in the Chemical segment and an increase of $64,721 in the Electronics segment offset by a $64,421 decrease in the Engineering segment.
Gross profit for the nine months ended December 31, 2025 decreased by $78,278. This decrease was primarily due to a $129,041 increase in the Electronics segment offset by a decrease of $59,190 in the Chemicals segment and a $148,129 decrease in the Engineering segment.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice